For example, the epigallocatechin-3-gallate supplement has been shown to improve insulin sensitivity and promote the functional recovery of insulin receptor substrate-1 in a model of nonalcoholic steatohepatitis [95]. Here, INS is linked to metabolic dysfunction-associated steatohepatitis.